TLPH
Talphera Inc.NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$36.99M
P/E Ratio
—
EPS
$-0.34
Beta
0.56
52W High
$1.57
52W Low
$0.38
50-Day MA
$0.82
200-Day MA
$0.90
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.02
PEG Ratio
—
About Talphera Inc.
Talphera Inc. is an innovative biotechnology company focused on developing cutting-edge therapies for rare diseases and significant unmet medical needs, primarily through its expertise in peptide-based therapeutics. The company boasts a robust pipeline aimed at addressing critical challenges in cancer treatment and other high-need health areas. With a strong commitment to research excellence and potential for transformative advancements in healthcare, Talphera offers institutional investors a unique opportunity to capitalize on the growth potential within the biopharmaceutical industry.
Fundamentals
| Revenue (TTM) | 28,000 |
| Gross Profit (TTM) | -218,000 |
| EBITDA | $-15.16M |
| Operating Margin | -48157.00% |
| Return on Equity | -114.70% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.34 |
| Price-to-Book | 2.17 |
| Price-to-Sales (TTM) | 1320.96 |
| EV/Revenue | 593.07 |
| EV/EBITDA | 0.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $50.05M |
| Float | $24.91M |
| % Insiders | 25.43% |
| % Institutions | 40.74% |
Historical Volatility
HV 10-Day
46.38%
HV 20-Day
68.17%
HV 30-Day
77.53%
HV 60-Day
80.61%
HV Rank
48.8%
Volatility is currently contracting
Data last updated: 4/28/2026